27.02.2020 14:36:23

Fighting The Deadly Coronavirus

(RTTNews) - The new coronavirus, COVID-19, which originated in China, has now spread to least 47 countries, infecting over 81,000 people and killing 3,000 people, with the majority of them in China.

A report released by the World Health Organisation on February 25, 2020, says "for the first time, since the onset of symptoms of the first identified case of COVID-19 on December 8, 2019, there have been more new cases reported from countries outside of China than from China."

A number of companies have joined the hunt for a treatment to tackle the new coronavirus. Nearly 124 studies have either commenced or are expected to do so shortly, with all but three taking place in China, STAT News reported sourcing the information to Informa Pharma Intelligence.

Let's take a look at some of the companies in the race to test Coronavirus drug.

Analysen zu Vaxart Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Co-Diagnostics Inc Registered Shs 0,71 -2,08% Co-Diagnostics Inc Registered Shs
AbbVie Inc 166,72 0,14% AbbVie Inc
Bio Blast Pharma Ltd. 1,11 1,83% Bio Blast Pharma Ltd.
Gilead Sciences Inc. 87,63 -0,74% Gilead Sciences Inc.
Johnson & Johnson 139,26 0,32% Johnson & Johnson
Regeneron Pharmaceuticals Inc. 701,80 -0,68% Regeneron Pharmaceuticals Inc.
Vaxart Inc Registered Shs 0,54 -0,64% Vaxart Inc Registered Shs